4/22/2013

HedgePath, a Florida-based firm specializing in cancer drug development, is merging with Commonwealth Biotechnologies, a Virginia biotech firm that is leaving bankruptcy protection. The combined firm will be called HedgePath Pharmaceuticals and will be based in Tampa, Fla.

Related Summaries